| RFC5 |
RFC5: Replication factor C subunit 5 |
HIST1H2AG |
HIST1H2AH, HIST1H2AI: Histone H2A type 1-H |
9.03 |
Evidence |
|
| RFC5 |
RFC5: Replication factor C subunit 5 |
HIST2H2AA |
HIST2H2AA3, H2AFO, HIST2H2AA: Histone H2A type 2-A |
9.03 |
Evidence |
|
| KCNJ6 |
KCNJ6, GIRK2, KATP2, KCNJ7: G protein-activated inward rectifier potassium chann |
LIN7B |
LIN7B, MALS2, UNQ3116/PRO10200, VELI2: Lin-7 homolog B |
9.027 |
Evidence |
|
| GADD45G |
GADD45G, CR6, DDIT2: Growth arrest and DNA-damage-inducible protein GADD45 gamma |
HIST1H2BD |
HIST1H2BD, H2BFB, HIRIP2: Histone H2B type 1-D |
9.027 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
ARF4 |
ARF4, ARF2: ADP-ribosylation factor 4 |
9.027 |
Evidence |
|
| PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
9.0 |
Evidence |
|
| PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
9.0 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
TUBB2A |
TUBB2A, TUBB2: Tubulin beta-2A chain |
9.0 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
9.0 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
9.0 |
Evidence |
O
|
| SP3 |
SP3: Transcription factor Sp3 |
ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
9.0 |
Evidence |
|
| RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
ARFGEF2 |
ARFGEF2, ARFGEP2, BIG2: Brefeldin A-inhibited guanine nucleotide-exchange protei |
9.0 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
9.0 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
9.0 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
9.0 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
9.0 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
9.0 |
Evidence |
|
| MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
9.0 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
DNMBP |
DNMBP, KIAA1010: Dynamin-binding protein |
9.0 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
9.0 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
9.0 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
9.0 |
Evidence |
|
| MOS |
MOS: Proto-oncogene serine/threonine-protein kinase mos |
SYK |
SYK: Tyrosine-protein kinase SYK |
9.0 |
Evidence |
|
| MOS |
MOS: Proto-oncogene serine/threonine-protein kinase mos |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
9.0 |
Evidence |
|
| ROCK2 |
ROCK2, KIAA0619: Rho-associated protein kinase 2 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
9.0 |
Evidence |
|
- 
-